Definition:

Hallucinogen-Induced Mood Disorder is a mental health condition characterized by a significant and persistent change in mood that is directly caused by the use of hallucinogenic substances.

Subtypes:

  1. Hallucinogen-Induced Depressive Disorder: This subtype is diagnosed when the individual experiences a predominant depressive mood for most of the time during the intoxication or withdrawal period of hallucinogen use.
  2. Hallucinogen-Induced Bipolar Disorder: This subtype is diagnosed when the individual experiences both depressive and manic symptoms during the intoxication or withdrawal period of hallucinogen use.

Symptoms:

  • Distinct and observable changes in mood, such as heightened euphoria, extreme sadness, or irritability.
  • Significant impairment in social or occupational functioning.
  • Onset of symptoms during or shortly after hallucinogen use.
  • Lack of alternative explanation for the mood disturbance.
  • Not better accounted for by another mental disorder.

Treatment:

Treatment for Hallucinogen-Induced Mood Disorder typically involves:

  • Biopsychosocial assessment to determine the extent of the disorder and any co-occurring mental health conditions.
  • Psychotherapy to help the individual cope with and manage their mood symptoms.
  • Supportive counseling to address any underlying issues related to substance use.
  • Pharmacotherapy may be considered in certain cases, but it is not the primary treatment approach.
  • Education and psychoeducation to provide the individual with information about the disorder and promote understanding.

Prognosis:

The prognosis for Hallucinogen-Induced Mood Disorder is generally favorable with appropriate treatment and cessation of hallucinogen use. However, the long-term outcome may vary depending on individual factors and the presence of other mental health conditions.